P. Ahmad-nejad, C. Dempfle, C. Weiss, P. Bugert, M. Borggrefe et al., The G534E-polymorphism of the gene encoding the Factor VII-activating protease is a risk factor for venous thrombosis and recurrent events, Thrombosis Research, vol.130, issue.3, pp.441-444, 2012.
DOI : 10.1016/j.thromres.2012.02.009

R. O. Alabi, K. Glomski, C. Haxaire, G. Weskamp, S. Monette et al., ADAM10-Dependent Signaling Through Notch1 and Notch4 Controls Development of Organ-Specific Vascular BedsNovelty and Significance, Circulation Research, vol.119, issue.4, pp.519-531, 2016.
DOI : 10.1161/CIRCRESAHA.115.307738

H. Austin, C. De-staercke, C. Lally, I. D. Bezemer, F. R. Rosendaal et al., New gene variants associated with venous thrombosis: a replication study in White and Black Americans, Journal of Thrombosis and Haemostasis, vol.7, issue.3, pp.489-495, 2011.
DOI : 10.1111/j.1538-7836.2009.03544.x

F. Banno, T. Kita, J. A. Fernández, H. Yanamoto, Y. Tashima et al., Exacerbated venous thromboembolism in mice carrying a protein S K196E mutation, Blood, vol.126, issue.19, pp.2247-2253, 2015.
DOI : 10.1182/blood-2015-06-653162

B. Bayat, Y. Tjahjono, H. Berghöfer, S. Werth, H. Deckmyn et al., Choline Transporter-Like Protein-2Significance, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.35, issue.7, pp.1616-1622, 2015.
DOI : 10.1161/ATVBAHA.115.305259
URL : http://atvb.ahajournals.org/content/atvbaha/35/7/1616.full.pdf

R. Benedito and M. Hellström, Notch as a hub for signaling in angiogenesis, Experimental Cell Research, vol.319, issue.9, pp.1281-1288, 2013.
DOI : 10.1016/j.yexcr.2013.01.010

R. M. Bertina, B. P. Koeleman, T. Koster, F. R. Rosendaal, R. J. Dirven et al., Mutation in blood coagulation factor V associated with resistance to activated protein C, Nature, vol.369, issue.6475, pp.64-67, 1994.
DOI : 10.1038/369064a0

I. D. Bezemer, F. J. Van-der-meer, J. C. Eikenboom, F. R. Rosendaal, and C. J. Doggen, The Value of Family History as a Risk Indicator for Venous Thrombosis, Archives of Internal Medicine, vol.169, issue.6, pp.610-615, 2009.
DOI : 10.1001/archinternmed.2008.589

M. Bruzelius, M. J. Iglesias, M. Hong, L. Sanchez-rivera, B. Gyorgy et al., PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study, Blood, vol.128, issue.23, pp.59-66, 2016.
DOI : 10.1182/blood-2016-05-711846
URL : https://hal.archives-ouvertes.fr/hal-01479709

A. Buil, D. Trégouët, J. C. Souto, N. Saut, M. Germain et al., C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies, Blood, vol.115, issue.23, pp.4644-4650, 2010.
DOI : 10.1182/blood-2010-01-263038

C. Bulato, C. M. Radu, E. Campello, S. Gavasso, L. Spiezia et al., New Prothrombin Mutation (Arg596Trp, Prothrombin Padua 2) Associated With Venous ThromboembolismSignificance, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.36, issue.5, pp.1022-1029, 2016.
DOI : 10.1161/ATVBAHA.115.306914
URL : http://atvb.ahajournals.org/content/atvbaha/36/5/1022.full.pdf

R. M. Camire, Rethinking events in the haemostatic process: role of factor V and TFPI, Haemophilia, vol.20, issue.Suppl 4, pp.3-8, 2016.
DOI : 10.1111/hae.12428

I. Canobbio, C. Visconte, S. Momi, G. F. Guidetti, M. Zarà et al., Platelet amyloid precursor protein is a modulator of venous thromboembolism in mice, Blood, vol.130, issue.4, 2017.
DOI : 10.1182/blood-2017-01-764910

D. Smith, G. Hemani, and G. , Mendelian randomization: genetic anchors for causal inference in epidemiological studies, Human Molecular Genetics, pp.23-89, 2014.

S. Debette, S. Visvikis-siest, M. H. Chen, N. C. Ndiaye, C. Song et al., Identification of cis- and trans-Acting Genetic Variants Explaining Up to Half the Variation in Circulating Vascular Endothelial Growth Factor Levels, Circulation Research, vol.109, issue.5, pp.554-563, 2011.
DOI : 10.1161/CIRCRESAHA.111.243790

H. Deguchi, R. K. Sinha, P. Marchese, Z. M. Ruggeri, J. Zilberman-rudenko et al., Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va, Blood, vol.128, issue.14, 2016.
DOI : 10.1182/blood-2016-03-707679
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054698/pdf

J. Dennis, C. Y. Johnson, A. S. Adediran, M. De-andrade, J. A. Heit et al., The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies, Blood, vol.119, issue.10, pp.2392-2400, 2012.
DOI : 10.1182/blood-2011-10-383448

J. Dennis, V. Truong, D. Aïssi, A. Medina-rivera, S. Blankenberg et al., Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism, Journal of Thrombosis and Haemostasis, vol.3, issue.10, pp.1960-1970, 2016.
DOI : 10.1111/j.1538-7836.2005.01237.x
URL : https://hal.archives-ouvertes.fr/hal-01479707

D. Desch, . Ozel, . Ab, M. Halvrosen, . Jacobi et al., Exome sequencing in venous thromboembolic disease identifies excess mutation burden in PROS1, PROC Blood, vol.128, pp.1-2, 2016.

K. J. Dick, C. P. Nelson, L. Tsaprouni, J. K. Sandling, D. Aïssi et al., DNA methylation and body-mass index: a genome-wide analysis, The Lancet, vol.383, issue.9933, pp.1990-1998, 2014.
DOI : 10.1016/S0140-6736(13)62674-4

V. Djordjevic, M. Kovac, P. Miljic, M. Murata, A. Takagi et al., A novel prothrombin mutation in two families with??prominent thrombophilia- the first cases of antithrombin resistance in a Caucasian population, Journal of Thrombosis and Haemostasis, vol.11, pp.1936-1939, 2013.
DOI : 10.1111/jth.12367

O. Egeberg, Inherited antithrombin deficiency causing thrombophilia, Thrombosis Et Diathesis Haemorrhagica, vol.13, pp.516-530, 1965.

O. El-maarri, T. Becker, J. Junen, S. S. Manzoor, A. Diaz-lacava et al., Gender specific differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher methylation levels in males, Human Genetics, vol.37, issue.12, pp.505-514, 2007.
DOI : 10.4161/cc.5.2.2367

A. R. Folsom, M. Cushman, L. J. Rasmussen-torvik, S. R. Heckbert, and M. Y. Tsai, Prospective study of polymorphisms of the protein Z-dependent protease inhibitor and risk of venous thromboembolism, Thrombosis and Haemostasis, vol.97, pp.493-494, 2007.
DOI : 10.1160/TH06-11-0636

A. R. Folsom, N. S. Roetkler, S. T. Kelley, W. Tang, and N. Pankratz, Failure to replicate thrombomodulin genetic variant predictors of venous thromboembolism in African Americans, Blood, vol.130, issue.5, pp.688-690, 2017.
DOI : 10.1182/blood-2017-03-771329

S. Friso, V. Lotto, S. Choi, D. Girelli, M. Pinotti et al., gene influences plasma FVII concentrations and relates to coronary artery disease, Journal of Medical Genetics, vol.49, issue.3, pp.192-199, 2012.
DOI : 10.1136/jmedgenet-2011-100195

N. H. Gehring, U. Frede, G. Neu-yilik, P. Hundsdoerfer, B. Vetter et al., Increased efficiency of mRNA 3' end formation: a new genetic mechanism contributing to hereditary thrombophilia, Nature Genetics, vol.28, issue.4, pp.389-392, 2001.
DOI : 10.1038/ng578

M. Germain, D. I. Chasman, H. De-haan, W. Tang, S. Lindström et al., Meta-analysis of 65,734 Individuals Identifies TSPAN15 and SLC44A2 as Two Susceptibility Loci for Venous Thromboembolism, The American Journal of Human Genetics, vol.96, issue.4, pp.96-532, 2015.
DOI : 10.1016/j.ajhg.2015.01.019
URL : https://hal.archives-ouvertes.fr/hal-01259946

M. Germain, N. Saut, N. Greliche, C. Dina, J. Lambert et al., Genetics of Venous Thrombosis: Insights from a New Genome Wide Association Study, PLoS ONE, vol.42, issue.9, p.25581, 2011.
DOI : 10.1371/journal.pone.0025581.s003

C. Gieger, A. Radhakrishnan, A. Cvejic, W. Tang, E. Porcu et al., New gene functions in megakaryopoiesis and platelet formation, Nature, vol.2, issue.7376, pp.201-208, 2011.
DOI : 10.1038/nprot.2007.324

M. M. Gorski, L. A. Lotta, E. Pappalardo, H. G. De-haan, S. M. Passamonti et al., Single Nucleotide Variant rs2232710 in the Protein Z-Dependent Protease Inhibitor (ZPI, SERPINA10) Gene Is Not Associated with Deep Vein Thrombosis, PLOS ONE, vol.467, issue.7311, p.151347, 2016.
DOI : 10.1371/journal.pone.0151347.s001

A. Greinacher, J. Wesche, E. Hammer, B. Fürll, U. Völker et al., Characterization of the human neutrophil alloantigen-3a, Nature Medicine, vol.48, issue.1, pp.45-48, 2010.
DOI : 10.1038/nm.2070

J. H. Griffin, B. Evatt, T. S. Zimmerman, A. J. Kleiss, and C. Wideman, Deficiency of protein C in congenital thrombotic disease., Journal of Clinical Investigation, vol.68, issue.5, pp.1370-1373, 1981.
DOI : 10.1172/JCI110385

W. Hernandez, E. R. Gamazon, E. Smithberger, T. J. O-'brien, A. F. Harralson et al., Novel genetic predictors of venous thromboembolism risk in African Americans, Blood, vol.127, issue.15, pp.1923-1929, 2016.
DOI : 10.1182/blood-2015-09-668525

D. A. Hinds, A. Buil, D. Ziemek, A. Martinez-perez, R. Malik et al., Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis, Human Molecular Genetics, vol.25, issue.9, pp.1867-1874, 2016.
DOI : 10.1093/hmg/ddw037

D. Klarin, C. A. Emdin, P. Natarajan, M. F. Conrad, . Consortium et al., Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor, Circ Cardiovasc Genet, vol.10, p.1643, 2017.

L. M. Houlihan, G. Davies, A. Tenesa, S. E. Harris, M. Luciano et al., Common Variants of Large Effect in F12, KNG1, and HRG Are Associated with Activated Partial Thromboplastin Time, The American Journal of Human Genetics, vol.86, issue.4, pp.626-631, 2010.
DOI : 10.1016/j.ajhg.2010.02.016

J. Huang, M. Sabater-lleal, F. W. Asselbergs, D. Tregouet, S. Shin et al., Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation, Blood, vol.120, issue.24, pp.4873-4881, 2012.
DOI : 10.1182/blood-2012-06-436188

A. Van-hylckama-vlieg, L. E. Flinterman, L. A. Bare, S. C. Cannegieter, P. H. Reitsma et al., Genetic Variations Associated With Recurrent Venous Thrombosis, Circulation: Cardiovascular Genetics, vol.7, issue.6, pp.806-813, 2014.
DOI : 10.1161/CIRCGENETICS.114.000682

C. Infante-rivard and C. R. Weinberg, Parent-of-Origin Transmission of Thrombophilic Alleles to Intrauterine Growth-Restricted Newborns and Transmission-Ratio Distortion in Unaffected Newborns, American Journal of Epidemiology, vol.162, issue.9, pp.891-897, 2005.
DOI : 10.1093/aje/kwi293

P. V. Jenkins, O. Rawley, O. P. Smith, and J. S. Donnell, Elevated factor VIII levels and risk of venous thrombosis, British Journal of Haematology, vol.29, issue.6, pp.653-663, 2012.
DOI : 10.1161/ATVBAHA.109.190827

H. Jick, D. Slone, B. Westerholm, W. H. Inman, M. P. Vessey et al., VENOUS THROMBOEMBOLIC DISEASE AND ABO BLOOD TYPE. A COOPERATIVE STUDY, Obstetrical & Gynecological Survey, vol.24, issue.9, pp.1-539, 1969.
DOI : 10.1097/00006254-196909000-00009

N. S. Key, Epidemiologic and clinical data linking factors XI and XII to thrombosis. Hematology, pp.66-70, 2014.
DOI : 10.1182/asheducation-2014.1.66
URL : http://asheducationbook.hematologylibrary.org/content/2014/1/66.full.pdf

R. Kimura, S. Honda, T. Kawasaki, H. Tsuji, S. Madoiwa et al., Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients, Blood, vol.107, issue.4, pp.1737-1738, 2006.
DOI : 10.1182/blood-2005-09-3892

Y. Ko, L. Hsu, T. Hsu, C. Tsai, M. Teng et al., Functional polymorphisms of FGA, encoding ?? fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population, Human Genetics, vol.259, issue.1-2, pp.84-91, 2006.
DOI : 10.1161/01.ATV.19.12.3063

H. P. Kohler, R. A. Ariëns, P. Whitaker, and P. J. Grant, A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity, Thrombosis and Haemostasis, vol.80, p.704, 1998.

M. A. Lazzari, A. Sanchez-luceros, A. I. Woods, M. F. Alberto, and S. S. Meschengieser, Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosis, Hematology, vol.17, 2012.
DOI : 10.1179/102453312X13336169156618

Y. Li, I. D. Bezemer, C. M. Rowland, C. H. Tong, A. R. Arellano et al., locus, Journal of Thrombosis and Haemostasis, vol.70, issue.11, pp.1802-1808, 2009.
DOI : 10.1111/j.1538-7836.2009.03544.x
URL : https://hal.archives-ouvertes.fr/hal-01542943

S. Lindström, M. Germain, M. Crous-bou, E. N. Smith, P. Morange et al., Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study, & INVENT Consortium (2017) Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study, pp.897-902
DOI : 10.1016/j.jvs.2010.04.023

W. Liu, T. Yin, H. Okuda, K. H. Harada, Y. Li et al., Protein S K196E mutation, a genetic risk factor for venous thromboembolism, is limited to Japanese, Thrombosis Research, vol.132, issue.2, pp.314-315, 2013.
DOI : 10.1016/j.thromres.2013.05.008

A. Marchand, C. Proust, P. Morange, A. Lompré, and D. Trégouët, miR-421 and miR-30c Inhibit SERPINE 1 Gene Expression in Human Endothelial Cells, PLoS ONE, vol.7, issue.8, p.44532, 2012.
DOI : 10.1371/journal.pone.0044532.t003

I. Martinelli, V. De-stefano, and P. M. Mannucci, Inherited risk factors for venous thromboembolism, Nature Reviews Cardiology, vol.94, issue.3, pp.140-156, 2014.
DOI : 10.7326/0000605-200912150-00177

A. L. Matthews, P. J. Noy, J. S. Reyat, and M. G. Tomlinson, Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids, Platelets, vol.123, issue.4, pp.333-341, 2017.
DOI : 10.1073/pnas.1302553110

S. Middeldorp, Inherited thrombophilia: a double-edged sword. Hematology, pp.2016-2017, 2016.

Y. Miyawaki, A. Suzuki, J. Fujita, A. Maki, E. Okuyama et al., Thrombosis from a prothrombin mutation conveying antithrombin resistance, pp.2390-2396, 2012.

P. Morange, I. Bezemer, N. Saut, L. Bare, G. Burgos et al., A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24, American Journal of Human Genetics, vol.1, issue.86, pp.592-595, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00930143

P. Morange, N. Saut, G. Antoni, J. Emmerich, and D. Trégouët, Impact on venous thrombosis risk of newly discovered gene variants associated with FVIII and VWF plasma levels, Journal of Thrombosis and Haemostasis, vol.113, issue.1, pp.229-231, 2011.
DOI : 10.1182/blood-2008-11-190389

P. E. Morange and D. A. Tregouet, Lessons from genome-wide association studies in venous thrombosis, Journal of Thrombosis and Haemostasis, vol.361, issue.Suppl. 1, pp.258-264, 2011.
DOI : 10.1056/NEJMoa0904377

P. E. Morange, D. A. Tregouet, C. Frere, N. Saut, L. Pellegrina et al., Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort, British Journal of Haematology, vol.266, issue.1, pp.91-99, 2005.
DOI : 10.1161/01.CIR.101.13.1546

J. Navarro-fernández, M. E. De-la-morena-barrio, J. Padilla, A. Miñano, N. Bohdan et al., Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency, Thrombosis and Haemostasis, vol.116, issue.1, pp.146-154, 2016.
DOI : 10.1160/TH15-11-0871

A. R. Rezaie, Regulation of the Protein C Anticoagulant and Antiinflammatory Pathways, Current Medicinal Chemistry, vol.17, issue.19, pp.2059-2069, 2010.
DOI : 10.2174/092986710791233706

A. Rocanin-arjo, W. Cohen, L. Carcaillon, C. Frère, N. Saut et al., A meta-analysis of genome-wide association studies identifies ORM1 as a novel gene controlling thrombin generation potential, Blood, vol.123, issue.5, pp.777-785, 2014.
DOI : 10.1182/blood-2013-10-529628

I. M. Sainz, R. A. Pixley, and R. W. Colman, Fifty years of research on the plasma kallikrein-kinin system: From protein structure and function to cell biology and in-vivo pathophysiology, Thrombosis and Haemostasis, vol.98, pp.77-83, 2007.
DOI : 10.1160/TH07-04-0250

B. Saposnik, E. Lesteven, A. Lokajczyk, C. T. Esmon, M. Aiach et al., Alternative mRNA is favored by the A3 haplotype of the EPCR gene PROCR and generates a novel soluble form of EPCR in plasma, Blood, vol.111, issue.7, pp.3442-3451, 2008.
DOI : 10.1182/blood-2007-08-104968

O. Segers and E. Castoldi, Chapter 6 Factor V Leiden and activated protein C resistance, Advances in Clinical Chemistry, vol.49, pp.121-157, 2009.
DOI : 10.1016/S0065-2423(09)49006-1

B. Sennblad, S. Basu, J. Mazur, P. Suchon, A. Martinez-perez et al., Genome-wide association study with additional genetic and post-transcriptional analyses reveals novel regulators of plasma factor XI levels, Human Molecular Genetics, vol.26, pp.637-649, 2017.
DOI : 10.1093/hmg/ddw401
URL : https://hal.archives-ouvertes.fr/hal-01479678

P. Simioni, D. Tormene, G. Tognin, S. Gavasso, C. Bulato et al., X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua), New England Journal of Medicine, vol.361, issue.17, pp.1671-1675, 2009.
DOI : 10.1056/NEJMoa0904377

N. L. Smith, M. Chen, A. Dehghan, D. P. Strachan, S. Basu et al., Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation, pp.1382-1392, 2010.

N. L. Smith, J. A. Heit, W. Tang, M. Teichert, D. I. Chasman et al., Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta-analysis of eight studies, Journal of Thrombosis and Haemostasis, vol.10, issue.4, pp.719-722
DOI : 10.1111/j.1538-7836.2012.04665.x

N. L. Smith, L. A. Hindorff, S. R. Heckbert, R. N. Lemaitre, K. D. Marciante et al., Association of Genetic Variations With Nonfatal Venous Thrombosis in Postmenopausal Women, JAMA, vol.297, issue.5, pp.489-498, 2007.
DOI : 10.1001/jama.297.5.489

N. L. Smith, J. E. Huffman, D. P. Strachan, J. Huang, A. Dehghan et al., Genetic Predictors of Fibrin D-Dimer Levels in Healthy Adults, Circulation, vol.123, issue.17, pp.1864-1872
DOI : 10.1161/CIRCULATIONAHA.110.009480

N. L. Smith, K. M. Rice, E. G. Bovill, M. Cushman, J. C. Bis et al., Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis, Blood, vol.117, issue.22, pp.6007-6011, 2011.
DOI : 10.1182/blood-2010-10-315473

I. Starikova, S. Jamaly, A. Sorrentino, T. Blondal, N. Latysheva et al., Differential expression of plasma miRNAs in patients with unprovoked venous thromboembolism and healthy control individuals, Thrombosis Research, vol.136, issue.3, pp.566-572, 2015.
DOI : 10.1016/j.thromres.2015.07.005

S. M. Stevens, S. C. Woller, K. A. Bauer, R. Kasthuri, M. Cushman et al., Guidance for the evaluation and treatment of hereditary and acquired thrombophilia, Journal of Thrombosis and Thrombolysis, vol.94, issue.457, pp.154-164, 2016.
DOI : 10.1097/AOG.0b013e3181ae9c64

P. Suchon, M. Germain, A. Delluc, D. Smadja, X. Jouven et al., Protein S Heerlen mutation heterozygosity is associated with venous thrombosis risk Scientific Reports, p.45507, 2017.
DOI : 10.1038/srep45507
URL : http://www.nature.com/articles/srep45507.pdf

L. Tang, H. Wang, X. Lu, X. Jian, B. Jin et al., Common Genetic Risk Factors for Venous Thrombosis in the Chinese Population, The American Journal of Human Genetics, vol.92, issue.2, pp.177-187, 2013.
DOI : 10.1016/j.ajhg.2012.12.013

L. Tang, W. Zeng, X. Lu, Q. Wang, H. Liu et al., polymorphisms as common genetic risk factors for venous thrombosis in the Chinese population, Journal of Thrombosis and Haemostasis, vol.117, issue.Suppl. 1, pp.1616-1625, 2014.
DOI : 10.1182/blood-2010-07-299099

W. Tang, S. Basu, X. Kong, J. S. Pankow, N. Aleksic et al., Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study, Blood, vol.116, issue.23, pp.5032-5036, 2010.
DOI : 10.1182/blood-2010-05-283739

D. A. Trégouët, A. Delluc, A. Roche, C. Derbois, R. Olaso et al., Is there still room for additional common susceptibility alleles for venous thromboembolism?, Journal of Thrombosis and Haemostasis, vol.157, issue.9, pp.1798-1802, 2016.
DOI : 10.1111/j.1365-2141.2011.09025.x

D. Trégouët, S. Heath, N. Saut, C. Biron-andreani, J. Schved et al., Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach, Blood, vol.113, issue.21, pp.5298-5303, 2009.
DOI : 10.1182/blood-2008-11-190389

S. Uitte-de-willige, V. Van-marion, F. R. Rosendaal, H. L. Vos, M. C. De-visser et al., Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis, Journal of thrombosis and haemostasis: JTH, pp.1305-1310, 2004.
DOI : 10.1016/S0140-6736(94)90286-0

S. Uitte-de-willige, M. C. De-visser, J. J. Houwing-duistermaat, F. R. Rosendaal, H. L. Vos et al., Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen ??' levels, Blood, vol.106, issue.13, pp.4176-4183, 2005.
DOI : 10.1182/blood-2005-05-2180

A. Van-hylckama-vlieg, L. E. Flinterman, L. A. Bare, S. C. Cannegieter, P. H. Reitsma et al., Genetic Variations Associated With Recurrent Venous Thrombosis, Circulation: Cardiovascular Genetics, vol.7, issue.6, pp.806-813, 2014.
DOI : 10.1161/CIRCGENETICS.114.000682

U. M. Vischer, von Willebrand factor, endothelial dysfunction, and cardiovascular disease, Journal of Thrombosis and Haemostasis, vol.100, issue.6, pp.1186-1193, 2006.
DOI : 10.1161/01.CIR.0000077912.12202.FC

C. Y. Vossen, . Van-hylckama, A. Vlieg, R. Teruel-montoya, S. Salloum-asfar et al., Identification of coagulation gene 3???UTR variants that are potentially regulated by microRNAs, British Journal of Haematology, vol.116, issue.5, pp.782-790, 2017.
DOI : 10.1160/TH16-01-0071

G. Wang, B. Chai, and L. Yang, MiR-128 and miR-125 regulate expression of coagulation Factor IX gene with nonsense mutation by repressing nonsense-mediated mRNA decay, Biomedicine & Pharmacotherapy, vol.80, pp.331-337, 2016.
DOI : 10.1016/j.biopha.2016.03.041

P. S. Wells, J. L. Anderson, D. K. Scarvelis, S. P. Doucette, and F. Gagnon, Factor XIII Val34Leu Variant Is Protective against Venous Thromboembolism: A HuGE Review and Meta-Analysis, American Journal of Epidemiology, vol.164, issue.2, 2006.
DOI : 10.1093/aje/kwj179
URL : https://academic.oup.com/aje/article-pdf/164/2/101/167693/kwj179.pdf

N. A. Zakai, P. L. Lutsey, A. R. Folsom, S. R. Heckbert, and M. Cushman, Total tissue factor pathway inhibitor and venous thrombosis, Thrombosis and Haemostasis, vol.104, issue.2, pp.207-212, 2010.
DOI : 10.1160/TH09-10-0693
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943145/pdf

Q. Zhu, M. Yamakuchi, S. Ture, L. Garcia-hernandez, M. Ko et al., Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion, Journal of Clinical Investigation, vol.124, issue.10, pp.4503-4516, 2014.
DOI : 10.1172/JCI71245DS1
URL : http://www.jci.org/articles/view/71245/files/pdf

N. Zwingerman, I. Kasasm, V. Truong, D. Aïssi, J. Dennis et al., Role of DNA methylation in candidate genes regions on tissue plasminogen activator levels, Journal of Thrombosis and Haemostasis, vol.13, issue.2, p.73, 2015.